Literature DB >> 26014930

In Vitro and In Vivo Efficacy of Amphotericin B Combined with Posaconazole against Experimental Disseminated Sporotrichosis.

Débora Nunes Mario1, Josep Guarro1, Janio Morais Santurio2, Sydney Hartz Alves2, Javier Capilla3.   

Abstract

We evaluated the combination of posaconazole with amphotericin B in vitro and in a murine model of systemic infections caused by Sporothrix brasiliensis and Sporothrix schenckii sensu stricto. In vitro data demonstrated a synergistic effect, and although posaconazole alone was effective against sporotrichosis, efficacy in terms of survival and burden reduction was increased with the combination. This combination might be an option against disseminated sporotrichosis, especially when itraconazole or amphotericin B at optimal doses are contraindicated.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26014930      PMCID: PMC4505257          DOI: 10.1128/AAC.00052-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  Successful treatment of terbinafine in a case of sporotrichosis.

Authors:  Daiane Heidrich; Cheila Denise Ottonelli Stopiglia; Luciana Senter; Gerson Vetoratto; Patricia Valente; Maria Lúcia Scroferneker
Journal:  An Bras Dermatol       Date:  2011 Jul-Aug       Impact factor: 1.896

2.  Disseminated sporotrichosis in a patient with hairy cell leukemia treated with amphotericin B and posaconazole.

Authors:  Paul E Bunce; Lin Yang; Soohun Chun; Sean X Zhang; Martina A Trinkaus; Larissa M Matukas
Journal:  Med Mycol       Date:  2011-05-26       Impact factor: 4.076

3.  Disseminated cutaneous sporotrichosis in an immunocompetent individual.

Authors:  Felix Boon-Bin Yap
Journal:  Int J Infect Dis       Date:  2011-06-29       Impact factor: 3.623

Review 4.  Fatal sporotrichosis.

Authors:  Christopher B Yelverton; Cloyce L Stetson; Ran H Bang; Justin W Clark; David F Butler
Journal:  Cutis       Date:  2006-10

Review 5.  Disseminated Sporothix schenckii in a patient with AIDS.

Authors:  S Hardman; I Stephenson; D R Jenkins; M J Wiselka; E M Johnson
Journal:  J Infect       Date:  2005-10       Impact factor: 6.072

6.  Different virulence levels of the species of Sporothrix in a murine model.

Authors:  I Arrillaga-Moncrieff; J Capilla; E Mayayo; R Marimon; M Mariné; J Gené; J Cano; J Guarro
Journal:  Clin Microbiol Infect       Date:  2009-07-14       Impact factor: 8.067

7.  Extracutaneous sporotrichosis in a patient with liver cirrhosis.

Authors:  Salvador Fonseca-Reyes; Francisco J López Maldonado; Roberto C Miranda-Ackerman; Ezequiel Vélez-Gómez; Paola Alvarez-Iñiguez; Fernando A Velarde-Rivera; E Patricia Ascensio-Esparza
Journal:  Rev Iberoam Micol       Date:  2007-03       Impact factor: 1.044

8.  Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America.

Authors:  Carol A Kauffman; Beatriz Bustamante; Stanley W Chapman; Peter G Pappas
Journal:  Clin Infect Dis       Date:  2007-10-08       Impact factor: 9.079

9.  Sporothrix brasiliensis, S. globosa, and S. mexicana, three new Sporothrix species of clinical interest.

Authors:  Rita Marimon; Josep Cano; Josepa Gené; Deanna A Sutton; Masako Kawasaki; Josep Guarro
Journal:  J Clin Microbiol       Date:  2007-08-08       Impact factor: 5.948

10.  In vitro evaluation of double and triple combinations of antifungal drugs against Aspergillus fumigatus and Aspergillus terreus.

Authors:  Eric Dannaoui; Olivier Lortholary; Françoise Dromer
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

View more
  4 in total

1.  Multicenter, International Study of MIC/MEC Distributions for Definition of Epidemiological Cutoff Values for Sporothrix Species Identified by Molecular Methods.

Authors:  A Espinel-Ingroff; D P B Abreu; R Almeida-Paes; R S N Brilhante; A Chakrabarti; A Chowdhary; F Hagen; S Córdoba; G M Gonzalez; N P Govender; J Guarro; E M Johnson; S E Kidd; S A Pereira; A M Rodrigues; S Rozental; M W Szeszs; R Ballesté Alaniz; A Bonifaz; L X Bonfietti; L P Borba-Santos; J Capilla; A L Colombo; M Dolande; M G Isla; M S C Melhem; A C Mesa-Arango; M M E Oliveira; M M Panizo; Z Pires de Camargo; R M Zancope-Oliveira; J F Meis; J Turnidge
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

Review 2.  Current Progress on Epidemiology, Diagnosis, and Treatment of Sporotrichosis and Their Future Trends.

Authors:  Anderson Messias Rodrigues; Sarah Santos Gonçalves; Jamile Ambrósio de Carvalho; Luana P Borba-Santos; Sonia Rozental; Zoilo Pires de Camargo
Journal:  J Fungi (Basel)       Date:  2022-07-26

3.  Monitoring Fungal Burden and Viability of Sporothrix spp. in Skin Lesions of Cats for Predicting Antifungal Treatment Response.

Authors:  Luisa Helena Monteiro de Miranda; Jéssica Nunes Silva; Isabella Dib Ferreira Gremião; Rodrigo Caldas Menezes; Rodrigo Almeida-Paes; Érica Guerino Dos Reis; Raquel de Vasconcellos Carvalhaes de Oliveira; Danuza Salles do Amaral de Araujo; Laerte Ferreiro; Sandro Antonio Pereira
Journal:  J Fungi (Basel)       Date:  2018-08-07

4.  Identification of two potential inhibitors of Sporothrix brasiliensis and Sporothrix schenckii in the Pathogen Box collection.

Authors:  Luana Pereira Borba-Santos; Taissa Vila; Sonia Rozental
Journal:  PLoS One       Date:  2020-10-14       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.